Atlas Trials

Trial of Memantine for Cognitive Impairment in Multiple Sclerosis

Clinical trial NCT00300716 · COMPLETED

Trial details

NCT number
NCT00300716
Sponsor
Oregon Health and Science University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Multiple SclerosisCognition Disorders
Start date
2004-04-01
Primary completion
2009-01-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.